Literature DB >> 10089913

Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease.

J Roesler1, S Heyden, M Burdelski, H Schäfer, H W Kreth, R Lehmann, D Paul, J Marzahn, M Gahr, A Rösen-Wolff.   

Abstract

Chronic granulomatous disease is an inherited disease characterized by the inability of phagocytes to generate normal amounts of superoxide, leaving patients susceptible to opportunistic, life-threatening infections. In the majority of cases, cytochrome b558 is absent in the X-chromosomal form of CGD. However, the neutrophils from six of nine X-linked CGD patients, reported here, expressed normal or decreased amounts of this cytochrome and are referred to as "variant" forms. In three of these six variant patients, a roughly proportional decrease in cytochrome b558 expression and production of H2O2 were found. In two cases this phenotype could be well explained by special splice mutations, whereas in the third case it was caused by a missense mutation, predicting Ser 193-->Phe. In the other three variant patients, cytochrome b558 expression and H2O2 production were clearly disproportionate as the generation of H2O2 was much more decreased than cytochrome expression. Missense mutations also were found in these cases. One of these mutations, predicting Leu 546-->Pro and affecting the putative nicotinamide adenine dinucleotide phosphate binding site, led to normal levels of cytochrome b558 expression and reduced H2O2 production. In the other two mutations, predicting Pro 339-->His and His 338-->Tyr, the putative flavin adenine dinucleotide binding site was affected. This could explain the corresponding uncommon phenotypes, characterized by zero or trace amounts of H2O2 production and the expression of relatively high amounts of nonfunctional or low functional cytochrome b558, respectively. The only missense mutation found that prevented the expression of any cytochrome b558 was caused by a predicted His 222-->Arg exchange in one of the three classic cases. The two other classic phenotypes were caused by splice mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089913     DOI: 10.1016/s0301-472x(98)00024-1

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.

Authors:  Yuka Okura; Masafumi Yamada; Futoshi Kuribayashi; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-02-10       Impact factor: 8.317

3.  Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.

Authors:  Baruch Wolach; Arnon Broides; Tal Zeeli; Ronit Gavrieli; Martin de Boer; Karin van Leeuwen; Jacov Levy; Dirk Roos
Journal:  J Clin Immunol       Date:  2011-05-21       Impact factor: 8.317

4.  Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Authors:  Harry R Hill; Nancy H Augustine; Robert J Pryor; Gudrun H Reed; Joshua D Bagnato; Anne E Tebo; Jeffrey M Bender; Brian M Pasi; Javier Chinen; I Celine Hanson; Martin de Boer; Dirk Roos; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

5.  Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation.

Authors:  Catharina Schuetz; Manfred Hoenig; Ansgar Schulz; Min Ae Lee-Kirsch; Joachim Roesler; Wilhelm Friedrich; Horst von Bernuth
Journal:  Eur J Pediatr       Date:  2006-11-14       Impact factor: 3.183

6.  Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort.

Authors:  Bijun Sun; Zeyu Zhu; Xiaoying Hui; Jinqiao Sun; Wenjie Wang; Wenjing Ying; Qinhua Zhou; Haili Yao; Jia Hou; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2022-07-07       Impact factor: 8.317

7.  The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.

Authors:  Jinqiao Sun; Min Wen; Ying Wang; Danru Liu; Wenjing Ying; Xiaochuan Wang
Journal:  BMC Med Genet       Date:  2017-11-13       Impact factor: 2.103

Review 8.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.